Global Drug Screening Market Analysis
According to Verified Market Intelligence, The Global Drug Screening Market was valued at USD 5.34 billion in 2017 and is projected to reach USD 11.50 billion by 2025, growing at a CAGR of 10.1% from 2018 to 2025.
What is Drug Screening?
Drug screening is a method used in order to detect illegal and some prescribed drugs in the blood, urine, and other biological samples. In this method, potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It involves screening of large libraries of chemicals for a particular biological activity in high-throughput screening assays. Drug screening tests are performed at schools, hospitals, and places of employment, for college and professional athletes, and post-accident drug testing. Increasing usage of drug supplements and alcohol, illegal consumption of steroids by athletes and growing number of drug abuse cases boosts the growth of drug screening market.
Global Drug Screening Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Growing drug & alcohol consumption, rising strictness of alcohol and drug testing laws, and increasing funds from government have been driving the global drug screening market. On the other hand, ban on alcohol consumption in several Islamic countries and prohibition of drug testing in some corporate organizations might hamper the overall growth at a global level.
Verified Market Intelligence narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Drug Screening Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.
Global Drug Screening Market Competitive Landscape
The "Global Drug Screening Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Alere, Inc., Drägerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and, Express Diagnostics International Inc. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.
Global Drug Screening Market Segmentation, by End user
• Workplace
• Criminal Justice Systems and Law Enforcement Agencies
• Drug Treatment Centers
• Pain Management Centers
• Drug Testing Laboratories
• Others
Global Drug Screening Market Segmentation, by Sample Type
• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other
Global Drug Screening Market Segmentation, by Application
• Analytical Instruments
o Immunoassay Analyzers
o Chromatography Instruments
o Breathalyzers
• Rapid Testing Devices
o Urine Testing Devices
o Oral Fluid Testing Devices
• Consumables
o Assay Kits
o Sample Collection Devices
o Calibrators and Controls
o Other Consumables
• Drug Screening Services
Global Drug Screening Market Geographic Scope
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
• Rest of the World
Research Methodology of Verified Market Intelligence:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Intelligence.
1 INTRODUCTION OF GLOBAL DRUG SCREENING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL DRUG SCREENING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL DRUG SCREENING MARKET, BY END USER:
5.1 Overview
5.2 Workplace
5.3 Criminal Justice Systems and Law Enforcement Agencies
5.4 Drug Treatment Centers
5.5 Pain Management Centers
5.6 Drug Testing Laboratories
5.7 Others
6 GLOBAL DRUG SCREENING MARKET, BY SAMPLE TYPE:
6.1 Overview
6.2 Urine Samples
6.3 Breath Samples
6.4 Oral Fluid Samples
6.5 Hair Samples
6.6 Other
7 GLOBAL DRUG SCREENING MARKET, BY PRODUCT AND SERVICE:
7.1 Overview
7.2 Analytical Instruments
7.2.1.1 Immunoassay Analyzers
7.2.1.2 Chromatography Instruments
7.2.1.3 Breathalyzers
7.3 Rapid Testing Devices
7.3.1.1 Urine Testing Devices
7.3.1.2 Oral Fluid Testing Devices
7.4 Consumables
7.4.1.1 Assay Kits
7.4.1.2 Sample Collection Devices
7.4.1.3 Calibrators and Controls
7.4.1.4 Others
7.5 Drug Screening Services
8 GLOBAL DRUG SCREENING MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World
9 GLOBAL DRUG SCREENING MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Alere
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Thermo Fisher Scientific
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Drägerwerk
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Labcorp
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Quest Diagnostics
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Alfa Scientific Designs
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Lifeloc
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 MPD Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Orasure
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development
10.10 Omega Laboratories
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development
10.11 Premier Biotech
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Development
10.12 Psychemedics
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Development
10.13 Roche
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Development
10.14 Shimadzu
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Development
10.15 Siemens Healthineers
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Development
11 Appendix
11.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Telecom and IT |
Pages : 131 |